Latest Updates Around The World
Drugmaker Piramal Pharma reported a net loss of Rs 136 crore in the third quarter, compared to a profit of Rs 4 crore a year ago. Revenue for the quarter ended December stood at Rs 2,140 crore, down 3% from the corresponding quarter of the previous fiscal, impacted by decline in Contract Development and Manufacturing […]
Microcap stocks Mangalam Drugs & Organics witnessed a series of bulk transactions on Wednesday with Vijay Kedia’s investment firm Kedia Securities Private Limited selling around 1.38 lakh shares worth Rs 48.35 lakh.The other sellers included Neo Apex Venture LLP (Rs 27.6 lakh), Epitome Trading and Investments (Rs 42 lakh) and Multiplier Share & Stock Advisors […]
